Theragen Etex Bio Institute is specialized genomics company developing innovative diagnosis tools and new drugs using the genomics and bioinformatics technologies. Theragen Etex Bio Institute’s world class analysis technologies are proven by number of high impact journal publications.

Proudly, we are the fifth organization in the world, which completed sequencing and assembly of an entire Human genome. In June 2013, we were recognized as the first group to identify genes that are related to Koran gastric cancer. In January 2014, we have secured the cover of the Nature Genetics with our research on the world’s first Minke Whale Genome.

We are providing genome-based customized research service, such as Genome, Transcriptome and Epigenome. In addition, we have personal genome service “HelloGene”, which is screening disease susceptibility, physical traits, drug sensitivity and so on.

Globally, we have made this personal genome service (HelloGene) contracts with UNIMEX, Philippine and Huangshi Zhongkang Physical Examination Center, China to construct Asian genome networks for accelerated global market entrance and expansion.

Based on these technologies and experiences, we are putting endless efforts to revolutionize personalized medicine and to become a global leader in human welfare and healthcare.